Literature DB >> 18199961

Lipid raft localization of ErbB2 in vestibular schwannoma and schwann cells.

Kevin D Brown1, Marlan R Hansen.   

Abstract

HYPOTHESIS: ErbB2 resides in lipid rafts (regions of receptor regulation) in vestibular schwannoma (VS) cells.
BACKGROUND: ErbB2 is a growth factor receptor critical for Schwann cell (SC) proliferation and development. ErbB2 localization and activity may be regulated by merlin, an adaptor protein deficient in VS. Lipid rafts are microdomains in the plasma membrane that amplify and regulate receptor signaling. Persistence of erbB2 in lipid rafts in VS due to merlin deficiency may explain increased VS cell growth.
METHODS: Protein extracts from VS or rat sciatic nerve (proximal or distal to a crush injury) were isolated into lipid raft and nonraft fractions and immunoblotted for erbB2, phosphorylated erbB2, and merlin (for sciatic nerve). Cultured VS cells were probed with anti-erbB2 antibody and a lipid raft marker, cholera toxin B (CTB).
RESULTS: ErbB2 moves to lipid rafts in proliferating SCs and is persistently localized to lipid rafts in VS cells. ErbB2 is phosphorylated (activated) in lipid rafts. ErbB2 colocalized with CTB in cultured VS cells, confirming raft targeting. Merlin also persistently localized to lipid rafts in SCs, and its relative phosphorylation increased in proliferating cells.
CONCLUSION: Lipid raft localization of erbB2 in proliferating SCs and in VS cells supports a critical role for lipid rafts in amplifying/regulating erbB2 signaling. Merlin resides in lipid rafts in SCs, and its phosphorylation increases in proliferating SCs, suggesting it regulates cell proliferation within lipid rafts. The absence of merlin in VS may therefore lead to persistent erbB2 localization to lipid rafts and increased cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199961     DOI: 10.1097/mao.0b013e31815dbb11

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  11 in total

Review 1.  Emerging therapeutic targets in schwannomas and other merlin-deficient tumors.

Authors:  Sylwia Ammoun; C Oliver Hanemann
Journal:  Nat Rev Neurol       Date:  2011-06-07       Impact factor: 42.937

2.  Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.

Authors:  Iram Ahmad; Augusta Fernando; Richard Gurgel; J Jason Clark; Linjing Xu; Marlan R Hansen
Journal:  Neurobiol Dis       Date:  2015-06-06       Impact factor: 5.996

3.  Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.

Authors:  Jennifer Kersigo; Lintao Gu; Linjing Xu; Ning Pan; Sarath Vijayakuma; Timothy Jones; Seiji B Shibata; Bernd Fritzsch; Marlan R Hansen
Journal:  Laryngoscope       Date:  2020-05-21       Impact factor: 3.325

4.  Contribution of persistent C-Jun N-terminal kinase activity to the survival of human vestibular schwannoma cells by suppression of accumulation of mitochondrial superoxides.

Authors:  Wei Ying Yue; J Jason Clark; Augusta Fernando; Frederick Domann; Marlan R Hansen
Journal:  Neuro Oncol       Date:  2011-06-22       Impact factor: 12.300

5.  Treatment of vestibular schwannoma cells with ErbB inhibitors.

Authors:  Matthew L Bush; Sarah S Burns; Janet Oblinger; Sholpan Davletova; Long-Sheng Chang; D Bradley Welling; Abraham Jacob
Journal:  Otol Neurotol       Date:  2012-02       Impact factor: 2.311

6.  The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.

Authors:  J Jason Clark; Matthew Provenzano; Henry R Diggelmann; Ningyong Xu; Skylar S Hansen; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2008-09       Impact factor: 2.311

7.  Inhibition of c-Jun N-terminal kinase activity enhances vestibular schwannoma cell sensitivity to gamma irradiation.

Authors:  Wei Ying Yue; J Jason Clark; Michael Telisak; Marlan R Hansen
Journal:  Neurosurgery       Date:  2013-09       Impact factor: 4.654

8.  p75NTR is highly expressed in vestibular schwannomas and promotes cell survival by activating nuclear transcription factor κB.

Authors:  Iram Ahmad; Wei Ying Yue; Augusta Fernando; J Jason Clark; Erika A Woodson; Marlan R Hansen
Journal:  Glia       Date:  2014-06-26       Impact factor: 7.452

9.  Schwannomas provide insight into the role of p75(NTR) and merlin in Schwann cells following nerve injury and during regeneration.

Authors:  Elise Cheng; Marlan R Hansen
Journal:  Neural Regen Res       Date:  2016-01       Impact factor: 5.135

Review 10.  The biological underpinnings of radiation therapy for vestibular schwannomas: Review of the literature.

Authors:  Mark C Dougherty; Seiji B Shibata; Marlan R Hansen
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.